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A specific method for measurement of nitric oxide synthase The neuroneal NOS (nNOS, or NOS1) and the endothe-
enzymatic activity in peritoneal biopsies. lial NOS (eNOS, or NOS3) are constitutively expressed
Background. Nitric oxide (NO) is synthesized by NO syn- in cells in which their activities are controlled by intracel-thase (NOS) isoforms that are expressed in the peritoneum.
lular Ca21 levels. In contrast, the inducible NOS (iNOS,Thus far, NOS activity in the peritoneum has been assessed by
or NOS2) remains quiescent until its transcription is acti-nonspecific methods. We describe the application of a specific
method for determination of NOS activity in rat and human vated by mediators such as lipopolysaccharides and/or
peritoneal biopsies. cytokines [1]. Although iNOS activity is Ca21 indepen-
Methods. The l-citrulline assay is based on the stoechiometric dent in native conditions, Venema et al have shown thatproduction of NO and l-[3H]-citrulline from l-[3H]-arginine by
recombinant iNOS can be activated by exogenous Ca21NOS. The assay is technically difficult when applied on small
[3]. In addition to its involvement in neurotransmissionsamples with relatively low levels of NOS activity, which re-
quired specific procedures for extraction and samples pro- and defense against infection, NO controls systemic va-
cessing. Reaction parameters ensuring assay linearity in the sodilation and affects microvascular permeability [2, 4].
peritoneum were defined. Peritoneum lysates were also used
Thus, it is not surprising that NO is considered as afor immunoblot analysis to identify the NOS isoforms involved.
potential regulator of peritoneal permeability, particu-Results. A significant NOS activity is detected in the normal
peritoneum because of both Ca21-dependent and Ca21-indepen- larly in situations (long-term peritoneal dialysis or acute
dent NOS. The specificity of NOS activity has been demonstrated peritonitis) characterized by ultrafiltration failure [5–8].
by various controls, including the NOS inhibitor l-NMMA. Furthermore, recent studies have shown that NOS iso-
Competition experiments with l-valine and amino acid analy-
forms are expressed with variable intensity in humanses have reasonably excluded the interference of endogenous
and rat peritoneum and that eNOS is the prevailing iso-arginase and l-arginine, which both might underestimate NOS
activity. The procedure is sensitive; it detects a high range of form in the peritoneum vasculature [9, 10].
NOS activities as well as the appropriate NOS isoforms in To date, the NOS activity in the peritoneum has been
various tissues and conditions, as shown by correlations with assessed by measuring plasma or dialysate concentrations
immunoblot studies.
of nitrite and nitrate [6–8, 11, 12], the nitrite:l-arginineConclusions. We have adapted and characterized the l-citrul-
ratio [12], or cGMP [7, 11]. However, these three meth-line assay to measure specific NOS activities within the perito-
ods are limited because: (a) they detect by-products ofneum. The peritoneum lysate assayed for NOS activity can
also be used for characterizing NOS isoform expression by NO and therefore lack specificity; (b) they do not allow
immunoblot analysis. discrimination between Ca21-dependent and Ca21-inde-
pendent NOS activities; and (c) they could reflect sys-
temic, rather than local, activation of NOS isoforms. The
Nitric oxide (NO) is synthesized from l-arginine by a lack of direct demonstration of endogenous NOS activity
family of three NO synthase (NOS) isoforms that are at the tissue level has even raised the question of whether
expressed in a large variety of tissues and cells [1, 2]. it is present in the normal peritoneum [6–8].
The biochemical transformation of l-arginine by NOS
isoforms results in the stoechiometric production of NOKey words: nitric oxide, peritoneum, l-arginine, l-citrulline assay, in-
fection, neurotransmission, dialysis membrane permeability. and l-citrulline. That chemical reaction is the basis of the
l-citrulline assay, a simple, sensitive, and specific methodReceived for publication January 4, 1999
that is now the most recognized assay for NOS enzymaticand in revised form June 14, 1999
Accepted for publication August 20, 1999 activity [13, 14]. This technique is based on the conver-
sion of l-[3H]-arginine to l-[3H]-citrulline, with control 2000 by the International Society of Nephrology
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reactions (blanks) performed either (a) with a specific extraction. The frozen samples were finely grounded in a
specific mortar containing liquid nitrogen (Resco Trade,inhibitor of NOS, (b) in absence of the cofactor nicotin-
amide adenine dinucleotide phosphate (NADPH), or Kortrijk, Belgium) and suspended in (2 mL/g of tissue)
ice-cold buffer [50 mmol/L Tris, pH 7.4, containing 0.1(c) with an extract that has been boiled prior to the
incubation. Because the reaction can be performed with mmol/L egtazic acid (EGTA), 0.1 mmol/L ethylenedi-
aminetetraacetic acid (EDTA), 2 mmol/L b-mercapto-or without Ca21, it can discriminate between Ca21-depen-
dent and Ca21-independent NOS activities. The l-citrul- ethanol, 5 mmol/L leupeptin, and 4 mmol/L pepstatin].
The suspension was homogenized in three passes of 10line assay has been widely used to demonstrate NOS
activity in a variety of cells and tissues [13, 14]. However, seconds at 22,000 r.p.m. with Ultra-Turraxt (Labortech-
nik, Staufen, Germany) and then sonicated with 10 briefNOS activity is relatively unstable, and the l-citrulline
assay is technically difficult when applied on small, pulses at 40% intensity (Branson Sonifier B-12, Danbury,
CT, USA). The resulting homogenate was centrifugedbiopsy samples or on tissues with relatively low levels
of NOS activity [13, 14]. at 6000 3 g (Sigma 113 centrifuge, Osterode am Harz,
Germany) for 10 minutes at 48C. The postnuclear super-In this study, we have adapted and characterized the
l-citrulline assay in order to measure the specific Ca21- natant (total protein extract) was kept on ice for determi-
nation of protein concentrations with the Bradforddependent and Ca21-independent NOS activities within
the peritoneum. We show that the peritoneum lysate method (Bio-Rad, Melville, NY, USA) and for amino
acid analysis with ion-exchange chromatography (Bio-assayed for NOS activity can also be used for studying the
expression of the NOS isoforms by immunoblot analysis. chrom 20 Analyzer; Pharmacia Biotech, Rosendaal, The
Netherlands). All samples were aliquoted and stored at
2808C.
METHODS
Tissue samples Measurement of nitric oxide synthase
enzymatic activitySamples of rat visceral peritoneum were taken from
eight-week-old male Sprague-Dawley rats (N 5 5, 307 6 6 Nitric oxide synthase activity was measured by the
conversion of l-[3H]-arginine to l-[3H]-citrulline [13].g body wt) with access to standard rat chow. Preliminary
studies for arginase and nonspecific NOS activities were One volume of tissue extract containing 300 to 400 mg
of total protein and 20 mmol/L CHAPS was added toconducted in 12-week-old rats (N 5 4, body weight: 397 6
18 g). The animals were anesthetized with 90 mg/kg 200 mL of reaction mixture [50 mmol/L Tris buffer, pH
7.4, containing 10 mmol/L dithiothreitol (DTT), 10subcutaneous (SC) sodium pentobarbital (Nembutal,
Ceva, Brussels, Belgium) and sacrificed by exsanguina- mmol/L THB4, 10 mg/mL calmodulin, 1 mmol/L NADPH,
4 mmol/L flavin adenine dinucleotide (FAD), 4 mmol/Ltion. The abdomen was opened by a midline incision for
tissue sampling. Some samples were similarly obtained flavin mononucleotide (FMN), 2 mmol/L l-arginine, and
1023 mCi/mL l-[3H]-arginine]. The assay was carried outin rats with peritonitis (intraperitoneal infection for 7
days). Samples from dog heart ventricle (N 5 6, obtained at 378C [15], and it was terminated with 2 mL of ice-cold
stop buffer (20 mmol/L CH3COONa, pH 5.5, contain-just after sacrifice) were used as a positive control for
NOS activity [15]. Paraumbilical biopsy samples of hu- ing 2 mmol/L EDTA, 0.2 mmol/L EGTA, and 1 mmol/L
l-citrulline). As l-[3H]-citrulline is neutral at pH 5.5, itman parietal peritoneum were obtained from a series of
six normal subjects (34 6 12 years old, 67% males) at was separated from the incubation mixture by cation
exchange resin (Dowex AG 50 W-X8; Bio-Rad) to whichthe time of nephrectomy (living donors, N 5 2) or lapa-
rotomy for benign surgery (N 5 4). Other human tissues, l-[3H]-arginine adhered. After elution with 2 mL of water,
l-[3H]-citrulline was quantitated by 16 mL liquid scintil-including kidney and brain, were obtained at autopsy.
The animal experiments were conducted in accord with lation counting (SL 3000; Intertechnique, Plaisir, France).
Background radioactivity (in percentage of total radioactiv-the National Institutes of Health Guide for the Care
and Use of Laboratory Animals. The use of the human ity) was measured in order to assess the quality of the l-
[3H]-arginine stock (background radioactivity below 3%).samples was approved by the University of Louvain Ethi-
cal Review Board. The possibility of arginase activity in the peritoneum ex-
tracts was studied by measuring the formation of l-[3H]-
Tissue extraction and processing citrulline in samples without (control conditions) or with
l-valine (concentrations from 1 mmol/L to 1 mmol/L).After washing in ice-cold phosphate-buffered saline,
peritoneal samples were divided in two parts. A small These conditions were controlled for experimental pH
[14, 16].part of the sample was used for fixation in 4% paraform-
aldehyde, paraffin embedding, and routine pathological The specific NOS activity (in pmol citrulline produced/
mg protein/min) was determined by subtracting countsexamination, whereas the major part of the sample was
snap frozen in liquid nitrogen and processed for protein obtained in the presence of 1 mmol/L l-NMMA, a spe-
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cific inhibitor of NOS, from counts obtained in the ab- washing, immunoblots were visualized after one minute
of enhanced chemiluminescence (Amersham, Littlesence of l-NMMA. Other controls for nonspecific NOS
activity, including incubations without NADPH and in- Chalfont, UK).
cubations with a previously boiled extract, were per-
Reagents and suppliesformed in preliminary experiments on four control rats
as well as in some subsequent experiments [13, 14]. l-[3H]-arginine was from Amersham and liquid scintil-
lation from Lumac (Groningen, The Netherlands). OtherAssays were systematically performed with Ca21 (1
mmol/L CaCl2) or without Ca21 (0 mmol/L CaCl2, 2 reagents and supplies were from Boehringer (Mann-
heim, Germany) and Sigma Chemical (St. Louis, MO,mmol/L EGTA, and 2 mmol/L EDTA) to measure total
versus Ca21-independent NOS activities [13]. The Ca21- USA).
dependent NOS activity was calculated as total NOS
Data analysisactivity minus Ca21-independent NOS activity. All assays
were performed in duplicate on aliquoted samples (to Data are presented as mean 6 sem. Comparisons be-
tween the results from different groups were performedavoid freezing/thawing cycles). The results were normal-
ized for protein content. using Student’s t-test or one-way analysis of variance, as
appropriate. Nonlinear regressions were made with theDetermination of linear parts of l-[3H]-citrulline for-
mation curves as a function of total protein concentration software Prismt (GraphPad, San Diego, CA, USA).
and incubation time. The formation of l-[3H]-citrulline
in rat peritoneum extracts was characterized as a func-
RESULTS
tion of the total protein concentration (from 50 to 800
Protein extraction and morphological examination ofmg of total protein in 200 mL of reaction mixture) for a
peritoneal biopsies30-minute incubation at 378C and as a function of the
incubation time (from 10 to 120 min) at 378C with a Protein extraction yielded 25 6 7 mg protein/mg tissue
in rat (N 5 5, tissue wt, 532 6 82 mg) and 49 6 8 mgprotein concentration of 400 mg in order to determine
the linear parts of the curves [13]. The latter experiment protein/mg tissue in human (N 5 6, tissue wt, 404 6 92
mg) index samples. Pathological examination confirmedwas performed with an extract from rat with peritonitis
in order to determine the linearity patterns of both total the nature of the tissue, its normal architecture, and the
lack of overt peritonitis in the normal samples, as welland Ca21-independent NOS activities [10].
as typical signs of peritonitis (edema, infiltrate) in in-
Immunoblot analysis fected rats (data not shown).
Sodium dodecyl sulfate-polyacrylamide gel electro-
Specificity of nitric oxide synthase activityphoresis (SDS-PAGE) and immunoblotting were per-
in the peritoneumformed to detect NOS isoforms [9] in the lysate used
for l-citrulline assay, with monoclonal antibodies raised Arginase is a major l-arginine–consuming enzyme
that might interfere with the NOS assay in the perito-against human eNOS and nNOS, and mouse iNOS
(Transduction Laboratories, Lexington, KY, USA), and neum [17]. The possibility of arginase activity in the non-
infected rat peritoneum was studied by measuring thea polyclonal antiserum against mouse iNOS (Biomol,
Plymouth Meeting, PA, USA). Briefly, the extracts were formation of l-[3H]-citrulline in control conditions (ab-
sence of l-valine) and with increasing concentrations ofsolubilized by heating at 958C for two minutes in sample
buffer [1.5% SDS, 10 mmol/L Tris-HCl, pH 6.8, 0.6% l-valine (an inhibitor of arginase) in the extract [14, 16].
As shown in Figure 1A, the addition of l-valine to theDTT, and 6% (vol/vol) glycerol]. Proteins (40 to 120 mg/
lane) were separated by electrophoresis through 0.1 3 extract had no significant influence on the production of
l-citrulline. This was true for l-valine concentrations rang-9 3 6 cm 7.5% acrylamide slabs and were transferred
to nitrocellulose. The membranes were briefly stained ing from 1 mmol/L to 1 mmol/L (higher concentrations
were associated with aspecific interactions with the resin).with Ponceau Red to check the efficiency of transfer.
Destained membranes were blocked for 30 minutes at Similarly, the presence of endogenous l-arginine in the
extracts might also interfere with the assay. Amino acidroom temperature in blotting buffer comprising 5% non-
fat dry milk, 50 mmol/L NaPO4, 150 mmol/L NaCl, 0.05% analysis showed that the levels of endogenous l-arginine
in the extracts used for the NOS assay were below theTween 20, pH 7.4, followed by incubation with the anti-
NOS antibody diluted in 2% bovine serum albumin, 50 detection limit of 1 mmol/L in the human and rat samples
tested (N 5 6).mmol/L NaPO4, 150 mmol/L NaCl, 0.05% Tween 20, pH
7.4, at 48C for 16 to 18 hours. The membranes were then To determine total versus nonspecific NOS activity
in the peritoneum (Fig. 1B), the l-citrulline assay waswashed and incubated for one hour at room temperature
with a peroxidase-labeled antimouse or antirabbit anti- performed in rat peritoneum samples (a) with l-NMMA,
(b) in absence of NADPH, or (c) after boiling the extract.body (1:5000 dilution; Dako, Glostrup, Denmark). After
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Fig. 1. Specificity of nitric oxide synthase (NOS) activity in the peritoneum. (A) Analysis of arginase activity: Effect of l-valine on the formation
of l-citrulline. To detect a potential interference between arginase and NOS in the peritoneum, the formation of l-citrulline (measured by the
conversion of l-[3H]-arginine to l-[3H]-citrulline) was studied in control conditions (absence of l-valine) and with increasing concentrations of l-valine
(from 1 mmol/L to 1 mmol/L) in peritoneal extracts from noninfected rats. When compared with control conditions (DCPM, 1153 6 15 or 100%),
the addition of l-valine to the extract has no significant effect on the production of l-citrulline (maximum increase, 4 6 4%; ANOVA, P 5 NS).
Determinations were performed in duplicate for three different samples. (B) Determination of total versus nonspecific NOS activity. Total NOS
activity (j; in pmol citrulline produced/mg protein/min) was measured by the conversion of l-[3H]-arginine to l-[3H]-citrulline in rat visceral peritoneum.
Nonspecific NOS activity was determined by three different controls: ( ) addition of the NOS inhibitor L-NMMA to the extract, ( ) removal of
the cofactor NADPH from the reaction mixture, and (h) boiling the extract prior to incubation. The nonspecific activities obtained with the three
controls are similar and represent 4 to 9% of the total NOS activity. Determinations were performed in duplicate in four different samples.
Nonspecific NOS activities (in pmol citrulline/mg pro- 0.003 pmol citrulline/mg protein/min in dog heart. The
NOS activity in the peritoneum was attributed to bothtein/min, percentage of total NOS) obtained with the
Ca21-dependent and Ca21-independent NOS isoforms.three types of controls (with l-NMMA, 0.018 6 0.006,
The Ca21-dependent NOS activity was 0.021 6 0.008 and9%; without NADPH, 0.01 6 0.003, 5%; boiled extracts,
0.016 6 0.005 pmol citrulline/mg protein/min in rat and0.008 6 0.005, 4%) were similar. The mean background
human peritoneum, respectively. The Ca21-independentradioactivity for these experiments was 2.25%.
NOS activity was 0.03 6 0.006 and 0.017 6 0.006 pmol
Determination of nitric oxide synthase activities in citrulline/mg protein/min in rat and human peritoneum,
respectively. The background radioactivity for these ex-human and rat peritoneum
periments averaged 2.7%.The relationships between l-[3H]-citrulline formation,
The intra-assay variability in peritoneal samples wasincubation time and total protein concentration were
2 6 0.4% for total NOS and 3 6 0.7% for Ca21-indepen-examined in the rat peritoneum (Fig. 2A) to define the
dent NOS activities (N 5 11). The interassay variabilityconditions ensuring assay linearity. An incubation time
was 7 6 2% for total NOS (N 5 7) and 8 6 1% forof 30 minutes at 378C corresponded to the linear part of
Ca21-independent NOS (N 5 5) activities. It must bethe curve of l-[3H]-citrulline formation with (total NOS)
noticed that NOS activity was age dependent in rats andand without (Ca21-independent NOS) Ca21 (left panel).
was affected by the freezing/thawing cycles of the samples.
Similarly, a total protein concentration of 300 to 400 mg The specific NOS activity was also determined in other
corresponded to the linear part of the assay (right panel). human tissues, including kidney and brain, characterized
These conditions were subsequently used to measure by their high endogenous activity [2], as well as in the
NOS enzymatic activities in all samples. peritoneum of an infected rat (Table 1). These experi-
A significant level of specific NOS activity was detected ments demonstrated the assay’s ability to detect high
in rat visceral peritoneum and human parietal peritoneum NOS activities and to differentiate between elevated
(Fig. 2B). This activity was comparable with that detected Ca21-dependent (brain and kidney samples) and Ca21-
in dog heart, the tissue used in our study as a positive independent (infected peritoneum) NOS activities.
control [15, 18]. Specific, total NOS activities reached
Immunoblot analysis of nitric oxide synthase isoforms0.051 6 0.012 pmol citrulline/mg protein/min in rat peri-
toneum and 0.033 6 0.008 pmol citrulline/mg protein/ The extracts used for the l-citrulline assay were sub-
mitted to SDS-PAGE and immunoblotting in order tomin in human peritoneum, as compared with 0.045 6
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Fig. 2. L-citrulline assay for specific, Ca21-de-
pendent and Ca21-independent nitric oxide
synthase (NOS) activities in rat and human
peritoneum. (A) l-[3H]-citrulline formation
curves as a function of incubation time (left
panel) and total protein concentration (right
panel). Symbols are: (j) total NOS; (s) Ca21-
independent NOS. The standard conditions
of the assay (incubation time, 30 min; protein
concentration, 300 to 400 mg) are in the linear
parts of the curves. Each determination was
done in duplicate in a sample of rat perito-
neum. Note that a rat with peritonitis was used
to perform the time course analysis in order
to get an increased total and Ca21-dependent
NOS. (B) Specific, total NOS activity (in pmol
citrulline produced/mg protein/min, j) was
measured by the conversion of l-[3H]-arginine
to l-[3H]-citrulline in rat visceral peritoneum
(N 5 5) and in human parietal peritoneum
(N 5 6). The assays were performed in the
presence or in the absence of Ca21 in order
to measure Ca21-dependent ( ) and Ca21-
independent (h) NOS activities. The values
shown are those obtained after subtraction of
nonspecific NOS (l-NMMA controls). Each
determination was done in duplicate for all
samples. Paired t-tests showed no statistically
significant differences between Ca21-depen-
dent and Ca21-independent NOS activities.
Table 1. Nitric oxide synthase (NOS) activities in human kidney, human brain, and rat infected peritoneum
NOS activity pmol citrulline/mg protein/min
Total Ca21-dependent Ca21-independent
Human kidney cortex 0.3780 60.0118 0.357960.0114 0.0201 60.0045
Human brain cortex 0.9345 60.0283 0.908160.0580 0.0263 60.0155
Rat infected peritoneum 0.5246 60.0031 0.361660.0095 0.1631 60.0065
Data are means 6 sem. The assay was performed in quadruplicate from one sample.
demonstrate the selective expression of the three NOS Subsequent analyses demonstrated that detection of
isoforms in these samples (Fig. 3A). Each monoclonal iNOS in the rat peritoneum by immunoblotting was re-
antibody recognized the appropriate NOS isoform, as lated to the white blood cell count in the peritoneal rinsing
shown by detection of a major band in control extracts solution, a value probably reflecting the amount of mac-
prepared from pituitary tissue (nNOS, 155 kd), endothe- rophages in the tissue (Fig. 3B). The intensity of the signal
lial cells (eNOS, 140 kd), or macrophages (iNOS, 130 kd). for iNOS was very weak or even undetected in some
It must be noticed that the monoclonal anti-iNOS cross- noninfected samples. Similar findings were obtained with
reacted with an upper band corresponding to eNOS (com- a polyclonal antiserum against iNOS (Fig. 3C).
pare the kidney and peritoneum samples). Each of the
two Ca21-dependent NOS isoforms was highly expressed
DISCUSSIONeither in brain (nNOS) or in kidney and peritoneum
In this study, we describe the adaptation of the l-citrul-(eNOS), whereas iNOS was found to be expressed with
line assay to measure NOS activities in human and ratvariable intensity in infected peritoneum and brain. De-
peritoneum samples. The specificity of the assay has beenspite a lack of specificity of the anti-iNOS, the expression
demonstrated by three types of controls, including theof iNOS in human brain (autopsy samples) was con-
NOS inhibitor l-NMMA. Competition experiments withfirmed by the resolution of the gels (allowing to discrimi-
l-valine and amino acid analyses have reasonably ex-nate the specific mass of the NOS isoforms) [10] and the
use of other anti-iNOS antibodies (data not shown). cluded the potential interference of endogenous arginase
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and l-arginine, which both might underestimate NOS ac-
tivity in the samples. The assay is sensitive; it detects a
high range of NOS activities as well as the appropriate
NOS isoforms in a variety of tissues and conditions. Fi-
nally, reproducibility is attested by a small intra-assay and
interassay variability. Thus far, the production of NO in
the peritoneum has been evaluated by measuring plasma
or dialysate levels of nitrate and nitrite, l-arginine, or
cGMP [6–8, 11, 12]. These methods lack specificity, do
not allow discrimination between NOS isoforms, and
might reflect systemic, rather than local, activation of NOS
activity. The latter point explains why local production
of NO in the normal peritoneum remains questioned [6–8].
The l-citrulline assay is now the usual assay for NOS
activity for several reasons [13, 14]. First, the assay is
relatively simple and highly reproducible, with a very
high sensitivity. Second, the availability of specific inhibi-
tors of NOS ensures the specificity of the assay. It is true
that citrulline can be formed via an alternate pathway
(the urea cycle), but the latter process is restricted to
liver and kidney, because most cells do not express the
enzymes catalyzing the formation of citrulline from orni-
thine [19]. Third, this method permits measurement of
specific NOS activity, as well as Ca21-dependent and
Ca21-independent NOS activities. However, NOS activ-
ity is labile and the assay is difficult to perform when
used on small samples (such as biopsies) or on tissues
or cells expressing low levels of NOS [13, 14].
Several technical modifications allowed us to apply the
Fig. 3. Immunoblot analysis of nitric oxide synthase (NOS) isoforms l-citrulline assay and to improve the yield of information
in tissue lysates. (A) Two micrograms of positive control (nNOS, rat obtained from one single peritoneal biopsy. First, the
pituitary; eNOS, bovine aortic endothelial cells; iNOS, mouse macro-
homogenization procedure was optimized to give a highphages) as well as lysates from human brain, human kidney, and infected
rat peritoneum (40 mg of total protein per lane) were submitted to SDS- yield of protein extraction, which allowed us to process
PAGE, transferred to nitrocellulose, and probed with a monoclonal small peritoneal samples, including human biopsies. Sec-
antibody against nNOS, eNOS, or iNOS (dilution 1:2500). Each anti-
ond, we had to select experimental conditions ensuringbody recognizes the appropriate isoform expressed in the control, as
shown by the major band at 155 kd (nNOS), 140 kd (eNOS), and 130 assay linearity in the peritoneum. As shown in Figure 2,
kd (iNOS). The lysates used for the l-citrulline assay contain the three the conditions routinely used for the reaction were inNOS isoforms, expressed according to the tissue of origin: nNOS is
the linear parts of the l-[3H]-citrulline formation curves.mostly expressed in the brain, eNOS in the kidney and peritoneum,
and iNOS (with variable intensity) in the brain and infected peritoneum. Third, the processing of the samples (frozen immediately
Note that the monoclonal anti-iNOS cross-reacts with an upper band after dissection, kept in liquid nitrogen during the initialcorresponding to eNOS in kidney and peritoneum samples. The film
steps of homogenization, and aliquoted to avoid freezing/was exposed for two minutes. (B) The detection of iNOS (130 kd) in
the peritoneum correlates with the amount of white blood cells (WBCs) thawing cycles) allowed a better preservation of NOS
in peritoneal rinsing solution. Peritoneum samples obtained from rats
activity than other methods. Fourth, the same postnu-with overt (lane 1), mild (lane 2), or apparently absent (lanes 3 and 4)
peritonitis were submitted to immunoblot analysis with the monoclonal clear supernatant obtained with our extraction protocol
anti-iNOS antibody (dilution 1:2500). The intensity of the signal corre- was used for the l-citrulline assay or for immunoblot
sponding to iNOS is correlated with the WBC count, taken as an index
analysis, as shown by the identification of the three NOSof the macrophage content of the peritoneum (a 15 mL saline solution
was used to rinse the peritoneum before sampling). Forty micrograms isoforms (Fig. 3). The latter point is particularly impor-
(lane 1) or 120 mg (lanes 2 through 4) of total protein were loaded. tant when considering that NOS isoforms have distinctLane C is the positive control for iNOS (mouse macrophages lysate).
intracellular distribution [2, 10], as they might escapeThe film was exposed for seven minutes. (C) Detection of iNOS (130
kd) in noninfected (lanes 1 and 2) and infected (lane 3) rat peritoneum detection by immunoblot if the analysis is performed
(100 mg total protein per lane), using a polyclonal antiserum against on a subcellular fraction. Thus, the great advantage—aiNOS (dilution 1:2000). Lane C is mouse macrophage lysate. The film
decisive gain for correlation studies—of the procedurewas exposed for seven minutes.
detailed in our study is that a single peritoneum biopsy
can be used for various experimental approaches that
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